FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting
August 12, 2020 10:07 ET
|
FibroGenesis
HOUSTON, Aug. 12, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, a clinical stage company developing fibroblast based therapeutic solutions for unmet medical needs, announced today new data supporting...
FDA Approves Two Emergency INDs for COVID-19 Outpatient Therapy
August 06, 2020 07:00 ET
|
ORGANICELL REGENERATIVE MEDICINE, INC
MIAMI, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine, Inc. (OTCBB: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,...
Histogen to Report Second Quarter 2020 Earnings on August 13, 2020
July 30, 2020 16:15 ET
|
Histogen Inc
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite...
Histogen to Present at the Canaccord Genuity 40th Annual Growth Conference
July 29, 2020 16:15 ET
|
Histogen Inc
SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite...
BioStem Technologies, Inc. Announces Update Regarding Timeline to Become Current Reporting with OTC Markets During Q4 2020
July 22, 2020 17:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 22, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
Histogen Inc. Announces Common Stock Purchase Agreement for up to $10 Million with Lincoln Park Capital Fund, LLC
July 20, 2020 16:10 ET
|
Histogen Inc
SAN DIEGO, July 20, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (“Histogen” or the “Company”) (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and...
Histogen Announces Completion of Patient Enrollment for its HST 001 Phase 1b/2a Trial for Androgenic Alopecia in Men
July 14, 2020 05:00 ET
|
Histogen Inc
SAN DIEGO, July 14, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, today...
BioStem Technologies, Inc. Announces Submission of Applications for Q-Codes from the Centers for Medicare and Medicaid Services (CMS)
July 02, 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 02, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM), a leading life sciences company specializing in the development and commercialization of perinatal...
BioStem Technologies, Inc. Announces Tissue Bank Certification in California and Maryland
June 26, 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, June 26, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life sciences company specializing in perinatal tissue-based...
UPDATE -- Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials
June 19, 2020 10:00 ET
|
Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced the successful...